Biotech Business - May 25, 2021
Elicera enters a new development phase
Elicera Therapeutics has announced that the subscription period for the company’s new share issue prior to the planned listing on Nasdaq First North Growth Market began May 24 and runs until June 8. The new share issue consists of a directed issue of a maximum of 6,500,000 Units, each consisting of one (1) new share […]
Biotech Business - May 25, 2021
Lytix Biopharma prepares for listing on Euronext Growth Oslo
The board of directors of Lytix Biopharma has decided to apply for a listing of the company on Euronext Growth, simultaneously carrying out a capital increase. Lytix Biopharma has decided to initiate the process to secure funding of the company’s development program, including phase II clinical trials in the US for the lead candidate LTX-315. […]
Biotech Business - April 20, 2021
Lipum becomes listed on Nasdaq First North
On Thursday, April 22, shares in Lipum will be traded on the Nasdaq First North Growth Market for the very first time. The company will ring Nasdaq’s opening bell, which has been specially transported to Umeå, to mark the occasion. Begin clinical trials in the spring of 2022 Lipum has developed a biological drug candidate […]
Biotech Business - March 31, 2021
Vaccibody explores potential listing on Nasdaq Global Markets in the US
Vaccibody has decided to change its financial reporting from NGAAP (Norwegian Generally Accepted Accounting Principles) and instead adopt IFRS (International Financial Reporting Standards) as its new accounting standard. Vaccibody has experienced a continued growing international interest in its stock, including a significant increase in its international investor base which has led to the company’s decision […]
Listing - March 8, 2021
Pharmiva to be listed on Nasdaq First North Growth Market
Today, on March 8th, the subscription period prior to listing of the Swedish femtech company Pharmiva begins. Pharmiva focuses on medical innovations in women’s health. The company develops and markets patented medical products, and is committed to finding solutions against the increasing global threat of antimicrobial resistance to antibiotics. Treatment of bacterial vaginosis The company’s […]
Business article - February 1, 2021
Hey there: Hanna Sjöström, CEO, GPX Medical
GPX Medical is building on a historic Swedish legacy of medical technology innovation and the company’s mission is to revolutionize the care of infants born preterm. GPX Medical was founded in Lund, Sweden, in 2016 and is developing NEOLA, a lung analyzer for continuous monitoring of the lungs of preterm-born infants using a technology that […]
